Single Point Partners, LLC Abb Vie Inc. Transaction History

Single Point Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $58,171 - $72,391	-439 Reduced 18.74%	1,903 $256,000
Q1 2023 Apr 06, 2023	BUY	$144.61 - $166.54 $25,451 - $29,311	176 Added 8.13%	2,342 $373,000
Q4 2022 Jan 10, 2023	BUY	$138.31 - $165.87 $691 - $829	5 Added 0.23%	2,166 $350,000
Q3 2022 Oct 07, 2022	BUY	$134.21 - $153.93 $36,505 - $41,868	272 Added 14.4%	2,161 $290,000
Q2 2022 Jul 29, 2022	BUY	$137.62 - $174.96 $75,415 - $95,878	548 Added 40.87%	1,889 $289,000
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $176,985 - $219,588	1,341 New	1,341 $217,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Single Point Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Single Point Partners, LLC with notifications on news.